Titre :
  • Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
Auteur : Suter, T. ; Procter, Marion ; van Veldhuisen, Dirk J ; Muscholl, Michael ; Carlomagno, Chiara ; Perren, Thimothy J. ; Passalacqua, Rodolfo ; Bighin, Claudia ; Klijn, J G ; Ageev, Fail T ; Hitre, Erika ; Groetz, Juergen ; Iwata, Hiroji ; Knap, Malgorzata ; Gnant, Michael ; Muehlbauer, Susanne ; Spence, Alison ; Gelber, R D ; Bergh, J. ; Piccart-Gebhart, Martine
Informations sur la publication : Journal of clinical oncology, 25, 25, (page 3859-3865)
Statut de publication : Publié, 2007-09
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Antibodies, Monoclonal -- administration & dosage
Antibodies, Monoclonal -- adverse effects
Antineoplastic Agents -- adverse effects
Breast Neoplasms -- drug therapy
Cardiovascular Diseases -- chemically induced
Disease-Free Survival
Female
Heart Failure -- chemically induced
Humans
Middle Aged
Receptor, erbB-2 -- metabolism
Note : Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:doi/10.1200/JCO.2006.09.1611
info:pii/JCO.2006.09.1611
info:pmid/17646669